ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2694

Associations Between Immune Checkpoint Molecules and Nasal Microbiome in ANCA-associated Vasculitis

Yoichi Nakayama1, Mirei Shirakashi2, Erika Furukawa3, Chikako Endo4, Tsuneo Sasai5, Yuya Tabuchi4, Ryosuke Hiwa5, Hideaki Tsuji5, Koji Kitagori6, Shuji Akizuki7, Ran Nakashima5, Kosaku Murakami3, Hajime Yoshifuji5 and Akio Morinobu8, 1Department of Rheumatology and Clinical Immunology, Kyoto University Graduate School of Medicine, Hirakata-shi, Osaka-fu, Japan, 2Department of Rheumatology and Clinical Immunology, Kyoto University Graduate School of Medicine, Kyoto, 3Division of Clinical Immunology and Cancer Immunotherapy, Center for Cancer Immunotherapy and Immunobiology, Graduate School of Medicine, Kyoto University, Kyoto, Kyoto, Japan, 4Department of Rheumatology and Clinical Immunology, Kyoto University Graduate School of Medicine, Kyoto, Kyoto, Japan, 5Department of Rheumatology and Clinical Immunology, Kyoto University Graduate School of Medicine, Kyoto, Japan, 6Occupational Welfare Division, Agency for Health, Safety and Environment, Kyoto University,, Kyoto, Kyoto, Japan, 7Department of Rheumatology and Clinical Immunology, Kyoto University Graduate School of Medicine, Kyoto City, Japan, 8Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Kyoto, Japan

Meeting: ACR Convergence 2024

Keywords: ANCA associated vasculitis, microbiome

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 19, 2024

Title: Abstracts: Vasculitis – ANCA-Associated II

Session Type: Abstract Session

Session Time: 11:00AM-12:30PM

Background/Purpose: Among patients with ANCA-associated vasculitis (AAV), several exhibit sinonasal involvement, especially in granulomatosis with polyangiitis (GPA) and eosinophilic granulomatosis with polyangiitis (EGPA). A recent study suggested that programmed death ligand 1 (PD-L1) expression in neutrophils is associated with dysfunction of NET degradation. Another study revealed that neutrophils from AAV patients highly expressed CD47 (the “don’t eat me” signal) and escaped from efferocytosis by macrophages expressing SIRPa, a ligand of CD47. Although several studies have shed light on the host microbiome, the connections between the nasal microbiome and autoimmune diseases remain frontier. We aimed to elucidate the association between the nasal microbiome and AAV (GPA, EGPA, and microscopic polyangiitis [MPA]) using next-generation sequencing and assessed correlations between these taxa and immune checkpoint molecules (PD-L1, CD47, and SIRPa).

Methods: This is a cross-sectional study. The nasal microbiome was compared among GPA, EGPA, and MPA. All patients with AAV were diagnosed based on Watts’ algorithm. Nasal samples were collected through oropharyngeal swabbing and analyzed by sequencing the bacterial 16S rDNA gene (V3-V4 region). Amplicon sequence variants (ASVs) were assigned in QIIME2 (2023.2) using the Greengenes 13_8. Bacterial taxa were assessed in the following analysis if their median abundance was >0% (relatively rare taxa was excluded). In each patient, monocytes, normal-density granulocytes (NDG) and low-density granulocytes (LDG) were isolated from peripheral blood using separation liquid. PD-L1, CD47, and SIRPa expression were assessed by flowcytometry.

Results: A total of 45 AAV patients were enrolled in the study (8 GPA, 16 EGPA, and 21 MPA). Demographic characteristics of patients are shown in Table 1. The bar plot of relative abundances of species is shown in Figure 1. The heatmap of correlations between nasal taxa and immune checkpoint molecule expressions is shown in Figure 2. Positive correlations between unclassified Propionibacteriaceae and CD47 of NDG and LDG, and SIRPa of monocytes were found in EGPA. CD47 of LDG showed a positive correlation with unclassified Stahpylococcus in GPA, while CD47 of NDG showed the opposite result. Positive correlation between unclassified Propionibacteriaceae and SIRPa of monocytes were found in GPA. Positive correlation between Corynebacterium accolens and PD-L1 of LDG, but not of NDG, was found in GPA. Unclassified Propionibacteriaceae was identified as Propionibacterium acnes and unclassified Staphylococcus was identified as Staphylococcus pettenkoferi using the Basic Local Alignment Search Tool (BLAST).

Conclusion: GPA showed distinct nasal microbiome components compared to MPA and EGPA. GPA and EGPA were suggested to be associated with the expression of immune checkpoint molecules on immune cells in relation to certain specific nasal bacteria, whereas no significant results were obtained for MPA. These results suggest that interactions between the nasal microbiome and host immune systems may differ in each AAV.

Supporting image 1

Table 1. Demographic characteristics of patients with ANCA-associated vasculitis (AAV).

Supporting image 2

Figure 1. The bar plot of relative abundances of species in each AAV.

Supporting image 3

Figure 2. The heatmap of correlation between nasal taxa and immune checkpoint molecule (PD-L1, CD47, and SIRPa) expressions in low-density granulocytes (LDG), normal-density granulocytes (NDG), and monocytes (mono).


Disclosures: Y. Nakayama: None; M. Shirakashi: None; E. Furukawa: None; C. Endo: None; T. Sasai: None; Y. Tabuchi: AbbVie/Abbott, 5, 6, 7, Alexion, 2, 6, Astellas, 6, Daiichi Sankyo, 6, Eisai, 7, Janssen, 6, 7, Kyowa Kirin, 6, Novartis, 6, 7, Pfizer, 6, Taisho, 6, UCB, 6; R. Hiwa: None; H. Tsuji: None; K. Kitagori: None; S. Akizuki: None; R. Nakashima: None; K. Murakami: None; H. Yoshifuji: None; A. Morinobu: None.

To cite this abstract in AMA style:

Nakayama Y, Shirakashi M, Furukawa E, Endo C, Sasai T, Tabuchi Y, Hiwa R, Tsuji H, Kitagori K, Akizuki S, Nakashima R, Murakami K, Yoshifuji H, Morinobu A. Associations Between Immune Checkpoint Molecules and Nasal Microbiome in ANCA-associated Vasculitis [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/associations-between-immune-checkpoint-molecules-and-nasal-microbiome-in-anca-associated-vasculitis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/associations-between-immune-checkpoint-molecules-and-nasal-microbiome-in-anca-associated-vasculitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology